Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124

Section 41

Fee — amendment — licence authorizing sterile fabrication

Cite as Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124, s. 41 · current to July 24, 2025 · regulation last amended May 31, 2025

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

If an application to amend an establishment licence seeks to add a building and the amendment seeks to authorize the holder to fabricate drugs in sterile dosage form at that building, the fee for the examination of the application for each building to be added is as follows: (a) in respect of drugs for human use, (i) in the case of a fee that is payable in a fiscal year set out in any of columns 2 to 5 of Schedule 3, the fee set out in item 1 for that fiscal year, and (ii) in the case of a fee that is payable in a fiscal year other than one set out in any of columns 2 to 5 of Schedule 3, the amount that is calculated in accordance with subsection 4(2); and (b) in respect of drugs for veterinary use only, (i) in the case of a fee that is payable in a fiscal year set out in any of columns 2 to 8 of Schedule 4, the fee set out in item 1 for that fiscal year, and (ii) in the case of a fee that is payable in a fiscal year other than one set out in any of columns 2 to 8 of Schedule 4, the amount that is calculated in accordance with subsection 4(2).
Read the Fees in Respect of Drugs and Medical Devices Order on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.